Livforsakringsbolaget Skandia, Omsesidigt Corcept Therapeutics Inc Transaction History
Livforsakringsbolaget Skandia, Omsesidigt
- $2.1 Billion
- Q2 2025
A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 113,158 shares of CORT stock, worth $8.99 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
113,158
Previous 19,660
475.57%
Holding current value
$8.99 Million
Previous $1.44 Million
475.54%
% of portfolio
0.39%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CORT
# of Institutions
469Shares Held
83.2MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.31 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$769 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$614 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$498 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$308 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $8.51B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...